48 related articles for article (PubMed ID: 9825657)
1. [Cytokines in acute myeloid leukemia].
Kiersnowska-Rogowska B; Rogowski F; Petelski T; Sawicka-Powierza J; Parfieńczyk A; Bodzenta-Lukaszyk A; Citko A; Jaroszewicz E
Pol Merkur Lekarski; 1998 May; 4(23):259-61. PubMed ID: 9825657
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic value of some cytokines levels in chronic myelogenous leukemia].
Kiersnowska-Rogowska B; Parfieńczyk A; Rogowski F; Citko A; Jaroszewicz E
Pol Merkur Lekarski; 2000 Mar; 8(45):129-32. PubMed ID: 10870415
[TBL] [Abstract][Full Text] [Related]
4. [Examination of interleukin levels and growth factor from blood platelets in leukemia].
Kiersnowska-Rogowska B; Rogowski F; Petelski T; Citko A; Jaroszewicz E; Bielawiec M
Pol Tyg Lek; 1996 May; 51(19-22):281-2, 288. PubMed ID: 9289710
[TBL] [Abstract][Full Text] [Related]
5. [Effect of cytostatic therapy on IL-1beta and L-selectin concentrations, synthesis, accumulation and excretion in patients with acute myeloid leukaemia].
Kiersnowska-Rogowska B; Parfieńczyk A; Rogowski F
Pol Merkur Lekarski; 2004 Oct; 17(100):341-4. PubMed ID: 15690697
[TBL] [Abstract][Full Text] [Related]
6. Implication of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Interleukin-3 (IL-3) in Children with Acute Myeloid Leukaemia (AML); Malignancy.
Elbaz O; Shaltout A
Hematology; 2001; 5(5):383-388. PubMed ID: 11399637
[TBL] [Abstract][Full Text] [Related]
7. Relations between IL-3-induced proliferation and in vitro cytokine secretion of bone marrow cells from AML patients.
Nowak R; Oelschlägel U; Gurth H; Range U; Albrecht S; Krebs U; Hietschold V; Ehninger G
Cytokine; 1999 Jun; 11(6):435-42. PubMed ID: 10346983
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics of T-cell immunity in patients with acute leukemia].
Parovichnikova EN; Gal'tseva IV; Vorob'ev IA; Savchenko VG
Ter Arkh; 2006; 78(7):18-25. PubMed ID: 16944746
[TBL] [Abstract][Full Text] [Related]
9. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
[TBL] [Abstract][Full Text] [Related]
10. Cytokine and adhesion molecule concentrations in blood of patients with B-cell chronic lymphocytic leukaemia with regard to disease progression.
Parfieńczyk A; Kiersnowska-Rogowska B; Rogowski F
Rocz Akad Med Bialymst; 2003; 48():90-4. PubMed ID: 14737950
[TBL] [Abstract][Full Text] [Related]
11. Intracellular IL-4, IL-10, and IFN-gamma levels of leukemic cells and bone marrow T cells in acute leukemia.
Park HH; Kim M; Lee BH; Lim J; Kim Y; Lee EJ; Min WS; Kang CS; Kim WI; Shim SI; Han K
Ann Clin Lab Sci; 2006; 36(1):7-15. PubMed ID: 16501231
[TBL] [Abstract][Full Text] [Related]
12. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K
Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-induced tumor necrosis factor receptor-related protein ligand subverts immunosurveillance of acute myeloid leukemia in humans.
Baessler T; Krusch M; Schmiedel BJ; Kloss M; Baltz KM; Wacker A; Schmetzer HM; Salih HR
Cancer Res; 2009 Feb; 69(3):1037-45. PubMed ID: 19155305
[TBL] [Abstract][Full Text] [Related]
14. Differential modulation of immune recognition molecules by interleukin-7 in human acute leukaemias.
Costello RT; Mallet F; Chambost H; Sainty D; Gastaut JA; Olive D
Eur Cytokine Netw; 1999 Mar; 10(1):87-96. PubMed ID: 10210778
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells.
Curti A; Pandolfi S; Aluigi M; Isidori A; Alessandrini I; Chiodoni C; Testoni N; Colombo MP; Baccarani M; Lemoli RM
Exp Hematol; 2005 Dec; 33(12):1521-30. PubMed ID: 16338495
[TBL] [Abstract][Full Text] [Related]
16. Effect of arsenic trioxide on cytokine expression by acute promyelocytic leukemia cells.
Jiang G; Bi K; Tang T; Zhang Y; Ren H; Jiang F; Ren Q; Zhen G; Liu C; Peng J; Guo G; Liu X; Tian Z
Chin Med J (Engl); 2003 Nov; 116(11):1639-43. PubMed ID: 14642127
[TBL] [Abstract][Full Text] [Related]
17. IL-4, IL-10 and IL-13 in acute myelogenous leukemia.
Bruserud O
Cytokines Cell Mol Ther; 1998 Sep; 4(3):187-98. PubMed ID: 9825844
[TBL] [Abstract][Full Text] [Related]
18. Growth factors in acute myeloid leukaemia.
Estey EH
Best Pract Res Clin Haematol; 2001 Mar; 14(1):175-87. PubMed ID: 11355930
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients.
de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA
Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527
[TBL] [Abstract][Full Text] [Related]
20. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts.
Bruserud Ø; Huang TS; Glenjen N; Gjertsen BT; Foss B
Haematologica; 2002 Jun; 87(6):584-95. PubMed ID: 12031914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
